It is special necessary to explore the influence of side group linked to pyrene core on the photophysical properties for constructing efficient pyrene-based blue-emitting materials. In this study, a series...
In this study, four new donor–acceptor (DA)‐type blue emitters (Py(5,9)BDPA, Py(5,9)BMTBA, Py(5,9)BDTBA, and Py (5,9)BTTBA) are developed by adopting benzene ring as A units and the diphenylamine (DPA) with different electron‐donating substituents as D units connected to 1,3‐positions and 5,9‐positions of pyrene ring, respectively. Gratifyingly, single‐crystal X‐ray analysis of the compounds demonstrates that the disgusting excimers in solid‐state could be effectively inhibited by the D units even the unsubstituted DPA resorting to the superiority of introducing D‐units at the 5,9‐positions of pyrene. The corresponding doped devices display ultrahigh luminance and extremely low efficiency roll‐off characteristics, especially for Py(5,9)BDPA, a roll‐off of external quantum efficiency is less than 4.9% when the luminance is up to 30 000 cd m−2, also showing good operation stability of devices. The optimized advanced device of the representative blue emitter Py(5,9)BDPA with a low manufacturing cost achieves extremely long LT95 (lifetime to 95% of the initial luminance) of 74 and 534 h at an initial luminance of 3000 and 1000 cd m−2, respectively. The ultralong lifetime of the emitter Py(5,9)BDPA is eye‐catching in the reported blue OLED lifetime and further demonstrates the practical applications in display and lighting of these DA‐type pyrene‐based blue emitters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.